Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine for sleep efficiency in advanced Parkinson's disease
2011-000056-42Phase 4Terminated
- Sponsor
- UCB
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) comparing Rotigotine with Placebo (2 arms). Primary endpoint: Change in Sleep Efficiency Index. Started Aug 2011; status: terminated.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2011-000056-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000056-42.